Search results
Kansas Sues Pfizer Over Covid-19 Vaccine’s Safety, Efficacy
Bloomberg Law· 7 days agoThe lawsuit was filed by state Attorney General Kris Kobach in Kansas District Court, Thomas County. Pfizer said its vaccine would prevent the transmission ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 1 week agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit
Reuters· 7 days ago, opens new tab filed in the District Court of Thomas County, the state said the New York-based drugmaker's alleged false statements violated the Kansas Consumer Protection Act. "Pfizer ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Motley Fool via Yahoo Finance· 7 hours agoLet's take a closer look. 1. Pfizer Pfizer (NYSE: PFE) is trading down by roughly 30% over the past...
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 7 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products ...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 3 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 7 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Pfizer CEO’s COVID-19 ‘rehearsal’ comment out of context
Politifact· 2 days agoA Threads post took a year-old statement by Pfizer CEO Albert Bourla out of context to say the...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 6 days agoWalter Orenstein, a member of MSD’s scientific advisory committee said: “Capvaxive is designed to...